Home
About
About The Guide to PHARMACOLOGY
About NC-IUPHAR
Database Content
Contributors
Sponsors
Citing
Linking to us
Disclaimer
Privacy and Cookie Policy
Targets
GPCRs
Ion channels
LGICs
VGICs
Other channels
Nuclear receptors
Kinases
Catalytic receptors
Transporters
Enzymes
Other protein targets
Target search
Target search tools
BLAST
Ligands
Ligand list
Ligand families
Ligand search
Diseases
Resources
Help
Tutorial
FAQ
Terms and symbols
Nomenclature guidelines
Publications
Drug approvals
Downloads
Download data and reports
Web services
Slides and posters
News
Immunopharmacology Meeting 2018
Latest news
Hot topics
Latest pairings
Concise Guide to PHARMACOLOGY
Useful links
Advanced search
Target search
Target search tools
BLAST
Ligand search
Pharmacology search
Immuno Portal
Malaria Portal
Home
About
Help
Home
Ligands
xeligekimab
xeligekimab
GtoPdb Ligand ID: 13784
Synonyms:
GR-1501 | GR1501
xeligekimab is an
approved drug
Compound class:
Antibody
Comment:
Xeligekimab (GR1501) is a human IgG4 monoclonal antibody that targets IL-17A [
2
].
Summary
Biological activity
Clinical data
References
Immunopharmacology
Bioactivity Comments
Xeligekimab binds human and primate IL-17A with high affinity [
2
]. It does not bind to mouse IL-17A or other IL-17 family peptides.
Selectivity at ligand targets
Key to terms and symbols
Click column headers to sort
Target
Sp.
Type
Action
Value
Parameter
Concentration range (M)
Reference
IL-17A
Hs
Antibody
Binding
9.9
p
K
d
-
2
⤷
p
K
d
9.9 (
K
d
1.39x10
-10
M) [
2
]
Description: Binding affinity determined by SPR
IL-17A/IL-17F
Hs
Antibody
Binding
8.6
p
K
d
-
2
⤷
p
K
d
8.6 (
K
d
2.47x10
-9
M) [
2
]
Description: Binding affinity determined by SPR